JP5073008B2 - Subject recruitment method, mediator server, software, recording medium - Google Patents
Subject recruitment method, mediator server, software, recording medium Download PDFInfo
- Publication number
- JP5073008B2 JP5073008B2 JP2010105014A JP2010105014A JP5073008B2 JP 5073008 B2 JP5073008 B2 JP 5073008B2 JP 2010105014 A JP2010105014 A JP 2010105014A JP 2010105014 A JP2010105014 A JP 2010105014A JP 5073008 B2 JP5073008 B2 JP 5073008B2
- Authority
- JP
- Japan
- Prior art keywords
- trial
- diary
- applicant
- terminal
- unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000007115 recruitment Effects 0.000 title claims description 30
- 238000000034 method Methods 0.000 title claims description 27
- 238000012544 monitoring process Methods 0.000 claims description 27
- 238000012790 confirmation Methods 0.000 claims description 16
- 230000008859 change Effects 0.000 claims description 11
- 230000005540 biological transmission Effects 0.000 claims description 9
- 230000036772 blood pressure Effects 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 8
- 230000036760 body temperature Effects 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 230000001953 sensory effect Effects 0.000 claims description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 3
- 238000010187 selection method Methods 0.000 claims description 3
- 229940116269 uric acid Drugs 0.000 claims description 3
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 210000000577 adipose tissue Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 210000001596 intra-abdominal fat Anatomy 0.000 claims description 2
- 238000005259 measurement Methods 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
Landscapes
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Description
この発明は、食品における治験、医薬品・対象疾患における治験、化粧品の治験などに自発的に参加する被験者を募集し、治験条件に適した被験者を選出するための被験者募集方法と、この方法に用いる仲介者のサーバと、ソフトウェアと、ソフトウェアを記録した記録媒体とに関するものである。 The present invention recruits subjects who voluntarily participate in clinical trials for foods, clinical trials for pharmaceuticals and target diseases, clinical trials for cosmetics, and the like, and a subject recruiting method for selecting subjects suitable for the clinical trial conditions and this method The present invention relates to an intermediary server, software, and a recording medium on which the software is recorded.
保健機能食品、サプリメント(栄養補助品)、健康食品、医薬品、化粧品、医療機器などの有効性と安全性を確認するために臨床試験(以下治験ともいう)が行われている。この治験は、食品や化粧品、医薬品などの開発者・販売者などの治験依頼者が実際に治験を行う医療機関などの治験実施者(治験実施機関)を決定し、また治験依頼者自身が治験実施者となって、治験実施者が被験者(以下、治験者ともいう。)に対して種々の治験を行うものである。 Clinical trials (hereinafter also referred to as clinical trials) are being conducted to confirm the effectiveness and safety of health functional foods, supplements (nutritional supplements), health foods, pharmaceuticals, cosmetics, medical devices, and the like. In this trial, a sponsor such as a developer or distributor of food, cosmetics, pharmaceuticals, etc., decides the trial investigator (clinical trial institution) such as a medical institution that actually conducts the clinical trial. The practitioner becomes a practitioner and the trial practitioner conducts various trials on the subject (hereinafter also referred to as the practitioner).
被験者の選定方法として特許文献1(特に段落0078〜0083)には、被験者を広告、インターネット、口コミ、縁故などによって募集し、治験内容に対応する対象被験者集団を選定しスクリーニングし、被験者の納得、同意を得て選定することが示されている。ここに治験毎に収集確認すべき被験者情報は異なるから、被験者情報収集不足は極力避けなければならない。そこで特許文献1では短い会話の中で被験者と募集担当者との間で信頼関係を築き、質問の方法を適切に管理することが必要であるという(段落0082,0083)。 Patent Document 1 (particularly paragraphs 0078 to 0083) as a method for selecting a subject recruits subjects by advertisement, the Internet, word-of-mouth, marginal relations, etc., selects and screens a target subject group corresponding to the contents of a clinical trial, It is shown to select with consent. Since the subject information to be collected and confirmed here differs from trial to trial, lack of subject information collection should be avoided as much as possible. Therefore, in Patent Document 1, it is necessary to establish a trust relationship between the subject and the recruiter in a short conversation and to appropriately manage the questioning method (paragraphs 0082 and 0083).
特許文献2は同一出願人によるものであるが、ここには被験候補者を選定するために治験参加希望者に質問を逐次形式で提示し、これに対する回答を質問ごとに修正不可として受けることにより、回答の信頼性を高めることが記載されている。また治験候補者(被験者となり得る候補者)を病院で検診することによって最終的な被験者(治験者)を決めるものである。 Patent Document 2 is by the same applicant, but here, in order to select a candidate for testing, questions are presented to the trial applicant in a sequential format, and the answer to this is received as uncorrectable for each question. , To improve the reliability of answers. In addition, a final test subject (study person) is determined by examining a clinical trial candidate (a candidate who can be a test subject) at a hospital.
特許文献1に記載された発明によれば、被験者を募集するに当たって被験者との会話を通して被験者情報を得るため、募集担当者との相性などにより取得情報の精度に不揃いが生じ易く治験条件に適合した被験者の選定精度が低下するという問題が生じる。また被験者毎に会話による質問・回答を繰り返すことになり、能率が悪いという問題が生じる。特許文献2に記載された発明によれば、治験参加希望者の自己申告を用いて治験候補者を決定すると共に、候補者として選定された治験参加希望者をさらに病院での検査や健康診断時の数値、また本人の記憶による申告などから治験者の適否を判断していたため、被験者選定の精度向上に限界があり、信頼性の向上にも限界が生じるという問題があった。 According to the invention described in Patent Document 1, in order to recruit subjects, subject information is obtained through conversations with subjects, and the accuracy of acquired information is likely to vary due to compatibility with recruiters, etc. There arises a problem that the selection accuracy of the subject is lowered. Moreover, the question and answer by conversation are repeated for each subject, and the problem that efficiency is bad arises. According to the invention described in Patent Document 2, the trial candidate is determined using the self-report of the trial applicant, and the trial applicant selected as a candidate is further examined at a hospital or during a medical examination. Because the investigator's suitability was judged based on the numerical value of this and the declaration by the person's memory, there was a problem that there was a limit in improving the accuracy of subject selection, and there was a limit in improving reliability.
この発明はこのような事情に鑑みなされたものであり、治験毎に適切な被験者を高い精度で能率良く選出することができ、被験者選定精度と信頼性向上に適する被験者募集/選定方法を提供することを第1の目的とする。またこの方法の実施に直接使用する仲介者のサーバを提供することを第2の目的とする。またこの方法の実施に用いるソフトウェアと、このソフトウェアを記憶した記憶媒体を提供することを第3および第4の目的とする。 The present invention has been made in view of such circumstances, and provides a method for recruiting / selecting subjects suitable for improving subject selection accuracy and reliability, capable of efficiently selecting appropriate subjects for each clinical trial with high accuracy. This is the first purpose. A second object is to provide an intermediary server that is directly used to implement this method. It is a third and fourth object of the present invention to provide software used for implementing this method and a storage medium storing this software.
この発明によれば第1の目的は、治験の選定条件に適合する被験者を治験実施者に紹介する仲介者が、インターネットを介して被験者を募集し選定するためのコンピュータを用いた被験者募集・選定方法において、
a.前記仲介者のサーバは、前記治験の選定条件および治験募集情報を予め記憶し、このサーバが有する募集画面提示部は治験参加希望者の端末機に対してこの記憶した治験募集情報を示す画面を提示し登録の申込みを促す工程、
b.前記仲介者のサーバは、前記予め記憶した治験の被験者選定条件とともに日誌のフォーマットを予め記憶し、この予め記憶した日誌のフォーマットは血圧、体温を含む数値データの記入欄と疲れの程度を含む主観的感覚データを直線上の位置で示す記入欄を有し、このサーバが有するID/PW提示部は前記治験参加希望者の端末機から登録の申込みを受けて治験参加希望者の端末機に対して前記予め記憶した日誌のフォーマットの読み込みを可能にするID/PWを送る工程、
c.前記仲介者のサーバが有する日誌フォーマット提示部は、治験参加希望者から送られるID/PWを受けて前記予め記憶した日誌のフォーマットおよび前記選定条件を治験参加希望者の端末機に送る工程、
d.前記仲介者のサーバは、前記治験参加希望者の端末機から定期的に送られる日誌フォーマットに記入済みの日誌を読み込んで日誌記憶部に記憶すると共に、日誌の入力情報を前記予め記憶した選定条件となる設定値と比較することによって前記治験参加希望者の体調を体調監視部で監視し治験実行に好適なタイミングを検知する工程、
e.前記仲介者のサーバは、このタイミングを検知すると、前記治験参加希望者の端末機から送られ前記日誌記憶部に記憶された日誌の所定期間分の入力情報を、前記体調監視部で監視した治験参加希望者の体調監視結果と共に前記治験実施者の端末機で読み取り可能にする工程、
f.前記仲介者のサーバが有する参加確認/同意処理部は、前記予め記憶した選定条件に適合する治験参加希望者の端末機に対して参加意思の確認/同意を促す工程、
g.前記仲介者のサーバが有するリスト作成部は、前記治験実施者の端末機に対して前記確認/同意を得た治験参加希望者を治験候補者とするリストを送付する工程、
以上のa〜gの工程を有するコンピュータを用いた被験者募集/選定方法、により達成される。
According to the present invention, a first object is to recruit and select subjects using a computer for introducing and selecting subjects via the Internet by an intermediary who introduces subjects who meet the selection conditions of the study to the study practitioner. In the method
a. The intermediary server stores the clinical trial selection conditions and clinical trial recruitment information in advance, and the recruitment screen presenting unit of the server displays a screen showing the stored clinical trial recruitment information for the terminal of the trial participation applicant. Process of presenting and encouraging registration,
b. The intermediary server pre-stores a diary format together with the pre-stored trial selection conditions for the trial, and the pre-stored diary format includes a column for numerical data including blood pressure and body temperature, and a subjectivity including the degree of fatigue. The ID / PW presentation section of this server has an application for registration from the terminal of the applicant who wishes to participate in the trial. Sending an ID / PW that enables reading of the previously stored diary format;
c. The diary format presentation unit of the mediator server receives the ID / PW sent from the trial applicant and sends the pre-stored diary format and the selection conditions to the trial participant's terminal.
d. The intermediary server reads the diary that is filled in the diary format periodically sent from the terminal of the trial applicant, stores the diary in the diary storage unit, and the pre-stored selection condition for the diary input information. A step of monitoring the physical condition of the applicant who wishes to participate in the trial by a physical condition monitoring unit by comparing with a set value to be detected and detecting a suitable timing for performing the trial ,
e. When the intermediary server detects this timing , the physical condition monitoring unit monitors the input information for a predetermined period of the diary sent from the terminal of the trial applicant and stored in the diary storage unit. Making it possible to read the physical condition monitoring result of the applicant who wishes to participate in the terminal of the investigator,
f. The participation confirmation / consent processing unit possessed by the server of the intermediary is a step of prompting confirmation / agreement of participation intention to a terminal of a trial applicant who meets the selection conditions stored in advance.
g. List generating unit that server of the intermediary has, the step of sending the list to the study candidate clinical trial participants who wish to obtain the confirmation / consent to the terminal of the trial practitioner,
This is achieved by a subject recruitment / selection method using a computer having the above steps a to g.
第2の目的は、請求項1の方法に用いる仲介者のサーバであって、
治験の選定条件および治験募集情報を予め記憶し、治験参加希望者の端末機に対してこの記憶した治験募集情報を提示し登録を促す募集画面提示部と、
前記治験参加希望者の端末機から入力される登録申込信号を受付ける参加申込み受付部と、
前記予め記憶した治験の選定条件とともに、血圧を含む数値データの記入欄と疲れの程度を含む主観的感覚データを直線上の位置で示す記入欄を有する日誌のフォーマットとを予め記憶し、前記登録申込信号を受け付けてこの日誌のフォーマットの読出し用のID/PWを参加申込者である応募者の端末機に送るID/PW送付部と、
ID/PWを受け付けて前記日誌のフォーマットおよび前記選定条件を治験参加希望者である応募者の端末機に提示する日誌フォーマット提示部と、
応募者の端末機から定期的に送られる日誌を読み込んで記憶する日誌記憶部と、
日誌の入力情報を選定条件となる設定値と比較し体調の変化を監視し治験実行に好適なタイミングを検知する体調監視部と、
このタイミングを検知すると、応募者の端末機から送られた日誌の所定期間分の入力情報を前記日誌記憶部から読み出して前記体調監視部の体調監視結果と共に治験実施者の端末機に送る入力情報送信部と、
治験実施者の端末機から送られてくる治験条件適合者に治験参加意思の確認/同意を取るための確認/同意処理部と、
治験参加意思の確認/同意を得た応募者を治験候補者として、この治験候補者のリストを作成し治験実施者の端末機による閲覧を可能にするリスト作成部と、
を備えることを特徴とする被験者募集仲介者のサーバ、により達成される。
The second object is a mediator server used in the method of claim 1,
Recruitment screen presentation unit for preliminarily storing clinical trial selection conditions and clinical trial recruitment information, and presenting the stored clinical trial recruitment information to the terminals of those who wish to participate in the clinical trial,
A participation application receiving unit that receives a registration application signal input from a terminal of the trial applicant.
In addition to the pre-stored clinical trial selection conditions, a diary format having an entry field for numerical data including blood pressure and an entry field for indicating subjective sensory data including the degree of fatigue on a straight line is stored in advance, and the registration is performed. An ID / PW sending unit that accepts an application signal and sends ID / PW for reading out the format of this diary to the terminal of the applicant who is a participating applicant;
A diary format presentation unit that accepts an ID / PW and presents the format of the diary and the selection conditions on the terminal of the applicant who is the applicant for the trial ;
A diary storage unit that reads and stores diaries periodically sent from the applicant's terminal;
A physical condition monitoring unit that compares the input information of the diary with a set value that is a selection condition , monitors changes in physical condition, and detects a suitable timing for performing the trial ;
When this timing is detected , input information for a predetermined period of the diary sent from the applicant's terminal is read from the diary storage unit and sent to the trial investigator's terminal together with the physical condition monitoring result of the physical condition monitoring unit A transmission unit;
A confirmation / consent processing unit for confirming / consenting the intention to participate in the trial to the trial condition conformant sent from the terminal of the trial investigator;
An applicant who has confirmed / consented the intention to participate in the trial as a trial candidate, creates a list of trial candidates, and allows the trial investigator's terminal to view the list,
It is achieved by a subject recruitment intermediary server characterized by comprising:
第3の目的は、請求項1の方法に用いるコンピュータのソフトウエアであって、サーバを、
治験の選定条件および治験募集情報を予め記憶し、治験参加希望者の端末機に対してこの記憶した治験募集情報を提示し登録を促す募集画面提示部と、
前記治験参加希望者の端末機から入力される登録申込信号を受付ける参加申込み受付部と、
前記予め記憶した治験の選定条件とともに、血圧を含む数値データの記入欄と疲れの程度を含む主観的感覚データを直線上の位置で示す記入欄を有する日誌のフォーマットとを予め記憶し、前記登録申込信号を受け付けてこの日誌のフォーマットの読出し用のID/PWを参加申込者である応募者の端末機に送るID/PW送付部と、
ID/PWを受け付けて前記日誌のフォーマットおよび前記選定条件を治験参加希望者である応募者の端末機に提示する日誌フォーマット提示部と、
応募者の端末機から定期的に送られる日誌を読み込んで記憶する日誌記憶部と、
日誌の入力情報を選定条件となる設定値と比較し体調の変化を監視し治験実行に好適なタイミングを検知する体調監視部と、
このタイミングを検知すると、応募者の端末機から送られた日誌の所定期間分の入力情報を前記日誌記憶部から読み出して前記体調監視部の体調監視結果と共に治験実施者の端末機に送る入力情報送信部と、
治験実施者の端末機から送られてくる治験条件適合者に治験参加意思の確認/同意を取るための確認/同意処理部と、
治験参加意思の確認/同意を得た応募者を治験候補者として、この治験候補者のリストを作成し治験実施者の端末機による閲覧を可能にするリスト作成部として機能させるためのプログラム、により達成される。
A third object is computer software used in the method of claim 1, wherein the server is
Recruitment screen presentation unit for preliminarily storing clinical trial selection conditions and clinical trial recruitment information, and presenting the stored clinical trial recruitment information to the terminals of those who wish to participate in the clinical trial,
A participation application receiving unit that receives a registration application signal input from a terminal of the trial applicant.
In addition to the pre-stored clinical trial selection conditions, a diary format having an entry field for numerical data including blood pressure and an entry field for indicating subjective sensory data including the degree of fatigue on a straight line is stored in advance, and the registration is performed. An ID / PW sending unit that accepts an application signal and sends ID / PW for reading out the format of this diary to the terminal of the applicant who is a participating applicant;
A diary format presentation unit that accepts an ID / PW and presents the format of the diary and the selection conditions on the terminal of the applicant who is the applicant for the trial;
A diary storage unit that reads and stores diaries periodically sent from the applicant's terminal;
A physical condition monitoring unit that compares the input information of the diary with a set value that is a selection condition, monitors changes in physical condition, and detects a suitable timing for performing the trial ;
When this timing is detected , input information for a predetermined period of the diary sent from the applicant's terminal is read from the diary storage unit and sent to the trial investigator's terminal together with the physical condition monitoring result of the physical condition monitoring unit A transmission unit;
A confirmation / consent processing unit for confirming / consenting the intention to participate in the trial to the trial condition conformant sent from the terminal of the trial investigator;
A program for creating a list of trial candidates and making them function as a list creation section that enables the trial site to be viewed by the applicant, with applicants who have confirmed / consented the intention to participate in the trial as trial candidates. Achieved.
第4の目的はこのソフトウェアを記憶した記憶媒体、により達成される。 The fourth object is achieved by a storage medium storing this software.
第1の発明は以上のように、治験参加希望者の登録を受けて(工程a)、被験者選定条件となる日誌のフォーマットを読み込むためのID/PWを送り(工程b)、このID/PWを受けて日誌のフォーマットを治験参加希望者の端末機に送り(工程c)、治験参加希望者が定期的に記入し仲介者のサーバに送る日誌を読み込んで記憶すると共に、日誌の入力情報から治験参加希望者の体調を監視し(工程d)、この日誌の所定期間分の入力情報を前記体調監視結果と共に治験実施者に送り(工程e)、治験実施者が選定条件に適合すると判断した治験参加希望者に対して参加意思の確認/同意を得た上で(工程f)、この確認/同意を得た治験参加希望者を治験候補者としてそのリストを治験実施者に送る(工程g)ものである。このため、治験ごとに適切な治験候補者を能率良くかつ信頼性高く選出することができる。 As described above, the first invention receives the registration of the trial applicant (step a), sends the ID / PW for reading the diary format as the subject selection condition (step b), and this ID / PW In response, the journal format is sent to the trial applicant's terminal (step c), and the journal that the prospective participant periodically fills in and sends to the mediator's server is read and stored, and the journal input information is used. The physical condition of the trial applicant is monitored (step d), and the input information for a predetermined period of this diary is sent to the trial investigator together with the physical condition monitoring result (step e), and the trial practitioner determines that the selection conditions are met. After obtaining confirmation / agreement of intention to participate from the trial applicant (step f), the trial applicant who obtained the confirmation / agreement is sent as a trial candidate to the list of trial participants (step g). ) For this reason, an appropriate clinical trial candidate can be selected efficiently and reliably for each clinical trial.
すなわち少なくとも登録の段階では、治験参加希望者(応募者)と仲介者(募集担当者)との間で会話を行う必要がなく、治験参加希望者が定期的に(例えば毎日)所定期間送り続ける日誌により治験者の選定を行うから、治験実施者側で選定基準を明確化できるからである。例えば、仲介者のサーバ(コンピュータ)では、日誌の記載内容に矛盾点がないか否か、所定期間を通して記載内容に振れが無いか否か、意図的な記載のつじつま合わせが無いか、などを入力情報の日付の経過による変化から判定でき、またサーバではこの入力情報の変化から正直な入力か否か、などの判断がし易くなる。さらに不正直な記入を発見しやすくなり、正直な治験応募者による情報を選別することにより、治験候補者の選出精度を向上させることができるものである。なおこれらの判定のもとになる日誌の送付期間(所定期間)は、サーバの持つタイマー機能により積算して監視すればよい。 In other words, at least at the registration stage, there is no need for a conversation between the applicant (applicant) and the intermediary (recruiter), and the applicant will continue to send regularly (for example, every day) for a predetermined period. This is because the investigator can clarify the selection criteria because the investigator is selected by diary. For example, at the mediator's server (computer), whether there are any inconsistencies in the contents of the diary, whether there is any fluctuation in the contents throughout the specified period, whether there is no intentional reconciliation, etc. It can be determined from the change of the input information due to the passage of the date, and the server can easily determine whether the input is an honest input from the change of the input information. Furthermore, it becomes easier to find an incorrect entry, and the selection accuracy of trial candidates can be improved by selecting information from honest trial applicants. The diary sending period (predetermined period) on which these determinations are made may be integrated and monitored by the timer function of the server.
また仲介者のサーバでは、例えば日誌の入力情報を設定値(設定範囲)と比較することによって治験参加希望者の体調を監視するので、体調の変化を検出して治験実行に好適なタイミングを知ることができる。このタイミングは例えば、感覚の変化、血圧や尿酸値などの数値の変化、鬱病などの状態の変化により検出できる。このタイミングを検知するとこの監視結果を、例えばこの日までの日誌入力情報と共に治験実施者に送るので、治験実施者では能率良く適切な治験者を選出することができるものである。 In addition, the mediator's server monitors the physical condition of the applicant who wants to participate in the trial by, for example, comparing the diary input information with a set value (set range), so the change in the physical condition is detected and the timing suitable for the trial execution is known. be able to. This timing can be detected by, for example, a change in sensation, a change in numerical values such as blood pressure or uric acid level, or a change in state such as depression. When this timing is detected, the monitoring result is sent to the investigator together with, for example, diary input information up to this date, so that the investigator can efficiently select an appropriate investigator.
第2の発明によれば、この第1の発明の実施に直接使用する仲介者のサーバが得られる。第3の発明によれば、請求項1の動作を行うためのソフトウェアが得られる。また第4の発明によれば、このソフトウェアを記憶した記憶媒体、例えば光ディスクが得られる。 According to the second aspect of the invention, an intermediary server that is used directly in the implementation of the first aspect of the invention is obtained. According to the third aspect, software for performing the operation of claim 1 is obtained. According to the fourth invention, a storage medium storing this software, for example, an optical disk is obtained.
工程dで行う治験参加希望者の体調監視では、日誌入力情報を例えば公知の統計解析手法を用いて体調や感情などの状態変化を検出する。ここで用いるコンピュータ統計解析ソフトは「SAS統計解析」(SASはStatistical Analysis System の略)などと称してすでに各種提供されているものである。仲介者のサーバ10では、所定期間あるいは全期間の入力情報をこのような統計解析ソフトを用いて、例えば入力情報の偏差値を求めたり、この偏差値からデータのバラツキ程度を求めたり、新たな入力情報の信頼性を求めて、体調や感情などの変化の検出精度を高めることができる。 In the physical condition monitoring of the trial applicant who is performed in the step d, the diary input information is detected using, for example, a known statistical analysis technique to detect a change in state such as physical condition or emotion. The computer statistical analysis software used here is already provided in various ways called “SAS statistical analysis” (SAS is an abbreviation of “Statistical Analysis System”). The intermediary server 10 uses such statistical analysis software for input information for a predetermined period or all periods, for example, to obtain a deviation value of the input information, to obtain a degree of variation in data from this deviation value, By seeking the reliability of input information, it is possible to improve the detection accuracy of changes such as physical condition and emotion.
請求項1の工程gでは、治験候補者リストは治験実施者がインターネットを介して仲介者のサーバにアクセスして閲覧してもよいが、仲介者がeメールやファクシミリや郵便などによって治験実施者に送り治験実施者が閲覧できるようにしてもよい。仲介者のサーバには、治験参加希望者の日誌の提出が遅れた時の情報、たとえば遅れた回数や遅れ日数なども送るようにすれば、治験参加希望者の熱意や誠実さも判断できて都合が良い。 In step g of claim 1, the trial candidate list may be browsed by the trial practitioner by accessing the mediator's server via the Internet. May be made available to the trial investigator for viewing. By sending information to the mediator's server when the submission of the diary of the applicant is delayed, such as the number of delays and the number of days delayed, it is possible to determine the enthusiasm and honesty of the applicant. Is good.
なお治験参加希望者が以前にも参加した実績を持つ場合には、その時の実績、例えば過去の治験における遅刻、無断欠席、連絡欠席、治験途中での脱落・中断、追跡調査への協力意欲などの過去の参加成績の実績を示すデータを信頼性評価資料として治験候補者のリストに合わせて出力するのがよい。この場合はこの信頼性情報によりそれぞれの被験者に対する信頼度を直ちに知ることができ、例えば治験実施者が被験者を選出したり治験を行う際の1つの有力な参考資料になる。 If the applicants who have participated in the trial have previously participated in the trial, the results at that time, such as lateness in the previous trial, absence without notice, contact absence, dropout / interruption during the trial, willingness to cooperate in follow-up studies, etc. It is preferable to output data indicating the results of past participation results as a reliability evaluation material according to the list of trial candidates. In this case, it is possible to immediately know the reliability of each subject by this reliability information, and for example, it becomes one powerful reference material when a trial practitioner selects a subject or conducts a clinical trial.
日誌のフォーマットには、治験の内容によるが、血圧、体温、歩数、体重、内臓脂肪レベル、BMI、カロリー活動量、心電図、血糖値、体脂肪、コレステロール値、中性脂肪、GOT、GPT、尿酸値、Hbalcなどのいずれかを記載できるようにすることができる(請求項2)。 The diary format depends on the content of the trial, but blood pressure, body temperature, number of steps, body weight, visceral fat level, BMI, caloric activity, electrocardiogram, blood sugar, body fat, cholesterol, neutral fat, GOT, GPT, uric acid Either a value, Hbalc, or the like can be described (claim 2).
これらのはデータは、治験参加希望者に別途送っておいた測定器具による測定結果を参加希望者自身が読み取って日誌に記載しても良いが、この測定器具自身を参加希望者の端末機(パソコン)に接続して日誌と一緒に仲介者のサーバに送るようにしても良い(請求項3)。また日誌フォーマットにはこれらの他に、治験参加希望者のその日の睡眠の深さ、そううつの程度、手あれの程度、にきびの程度などの主観的な感覚を、所定長さの直線上の位置で表現する書き込み欄を設けておいても良い(請求項4)。 These data may be recorded in the diary by the participant who wishes to read the measurement results obtained by the measuring instrument that was sent separately to the trial applicant. It may be connected to a personal computer and sent to the mediator's server together with the diary (claim 3). In addition to these, the diary format also shows subjective feelings such as the depth of sleep, the degree of depression, the degree of handing, the degree of acne, etc. on the straight line of a predetermined length. A writing field expressed as follows may be provided (claim 4).
仲介者のサーバでは、日誌入力情報を選定条件となる設定値と比較して体調を監視し、体調変化を検出するとその結果をこの日までの日誌入力情報と共に治験実施者の端末機に送ることができる(請求項5)。この場合には、治験実施者は体調変化の経過や他の入力情報などを参考にして一層精度の高い治験者の選定が可能になる。 The broker's server monitors the physical condition by comparing the diary input information with the set value that is the selection condition, and if a change in physical condition is detected, the result is sent to the investigator's terminal together with the diary input information up to this date. (Claim 5). In this case, the investigator can select the investigator with higher accuracy by referring to the change in physical condition and other input information.
図1において符号10は仲介者のサーバ(コンピュータ)、12は治験依頼者(治験依頼機関)の端末機、14(14A、14B、…)は治験実施者(治験実施機関)の端末機、16(16A、16B、…)は応募者である治験参加希望者の端末機である。これらはインターネット18を介して互いに接続されている。なおここでは各端末機12、14、16は単に治験依頼者(機関)、治験実施者(機関)、治験参加希望者(応募者)ともいう。 In FIG. 1, reference numeral 10 denotes an intermediary server (computer), 12 denotes a terminal of a trial requester (study requesting institution), 14 (14A, 14B,...) Denotes a terminal of the trial practitioner (trial institution), 16 (16A, 16B,...) Are terminals of applicants who wish to participate in the clinical trial. These are connected to each other via the Internet 18. Here, each of the terminals 12, 14, and 16 is also simply referred to as a clinical trial requester (institution), a clinical trial practitioner (institution), and a trial participation applicant (applicant).
治験実施者の端末機14は、仲介者のサーバ10との接続を可能にする専用アプリケーションを持ち、サーバ10との間で送受信する治験参加希望者16のデータの秘密保持機能を高めている。なおサーバ10と治験依頼者12、治験実施者14、治験参加希望者16との間でのデータの送受は、暗号通信やID(認証コード)やPW(パスワード)を用いることにより、秘密保持性を一層高めておく。 The investigator's terminal 14 has a dedicated application that enables connection with the mediator's server 10 and enhances the function of maintaining the confidentiality of the data of the trial participant 16 that transmits / receives data to / from the server 10. Note that data transmission / reception between the server 10 and the clinical trial requester 12, the clinical trial practitioner 14, and the clinical trial participant 16 is performed using encrypted communication, ID (authentication code), and PW (password), thereby maintaining confidentiality. Is further raised.
治験依頼者(医薬品などの生産者や販売者)12は、新薬や新しい食品、サプリメントなどを開発すると治験実施者14を決定する(図2のステップS100)。治験依頼者12が自ら治験実施者14となる場合(図2のステップS102)もある。治験依頼者12は治験の実施計画(デザイン)と概要を治験実施者14に提示し、決定する(ステップS104)。 The clinical trial requester (producer or seller of pharmaceuticals or the like) 12 determines the clinical trial practitioner 14 when developing a new drug, a new food, a supplement, or the like (step S100 in FIG. 2 ). In some cases, the clinical trial requester 12 becomes the clinical trial practitioner 14 (step S102 in FIG. 2). The clinical trial client 12 presents and determines the clinical trial implementation plan (design) and summary to the clinical trial practitioner 14 (step S104).
すなわち試験責任医師の選定、試験実施計画書の作成、実施医療機関の選定などを立案するものである。このデザイン作成において、治験依頼者12または治験実施者14は提携先医療機関倫理委員会(IRB)の承認を得るための資料を作成し、またIRB事務局を運営する(ステップS106)。その結果IRBの承認手続を完了すると、仲介者10は治験実施者14あるいは必要に応じて治験依頼者12と治験の打合せを行う(ステップS108)。この打合せでは、仲介者10と治験実施者14あるいは必要に応じて治験依頼者12と秘密保持契約や業務委受託契約を結び、治験(試験)概要を確認し、必要とする人数や日数や治験の困難性を考慮して費用の見積りを行う。 In other words, the selection of the investigator, the preparation of the study plan, the selection of the conducting medical institution, etc. are planned. In this design creation, the trial sponsor 12 or the trial practitioner 14 creates materials for obtaining approval from the partner medical institution ethics committee (IRB) and operates the IRB secretariat (step S106). As a result, when the IRB approval procedure is completed, the mediator 10 makes a meeting with the trial investigator 14 or the trial sponsor 12 as necessary (step S108). In this meeting, the intermediary 10 and the trial investigator 14 or, as necessary, the trial sponsor 12 and a confidentiality agreement or a business consignment agreement are concluded, the outline of the trial (examination) is confirmed, and the number of people, days, and clinical trials required. The cost is estimated in consideration of the difficulty.
次に本発明に係る治験参加希望者の募集から治験候補者選出の手続に入る(ステップS110)が、この手順については後記する。このステップS110で最適な治験候補者のリストが出ると、治験実施者14は治験候補者の診察と検診を行い治験に適合するか否かを判断し、適合した候補者に対して治験の詳細な説明を行いこの治験に納得し承諾したことを互いに確認する(ステップS112)。その結果治験実施者14は治験候補者が治験に参加できるか否かを判定する(ステップS114)。この結果は仲介者10のサーバに送られ実績データとして記憶される(ステップS116)。またこの結果は応募者10に仲介者から送られる(ステップS118)。 Next, a procedure for selecting trial candidates is started from recruitment of clinical trial applicants according to the present invention (step S110), which will be described later. When a list of optimal clinical trial candidates appears in this step S110, the clinical trial investigator 14 examines and examines the clinical trial candidates to determine whether they are suitable for the clinical trials. After confirming that the clinical trial has been accepted and accepted, it is mutually confirmed (step S112). As a result, the trial investigator 14 determines whether or not the trial candidate can participate in the trial (step S114). This result is sent to the server of the broker 10 and stored as performance data (step S116). The result is sent from the intermediary to the applicant 10 (step S118).
治験実施者14はこの候補者のリストから抽出し診察、検診を経て最終的に確定した被験者により治験を実行し治験の進行状況をモニタリングする(ステップS120)。この治験の実行と併行して仲介者10には被験者16の治験参加状況が報告され記録される(ステップS122)。すなわち被験者16の出欠状況、治験実施者14の指示を遵守して指示に従った投薬、報告等の行動をとっているか、などを監視するものである。 The investigator 14 extracts the candidate from the list of candidates, performs a clinical trial using subjects who are finally confirmed through examination and medical examination, and monitors the progress of the clinical trial (step S120). This is the intermediary 10 and run in parallel of the trial is recorded is reported clinical trial participation of the subject 16 (step S122). In other words, the attendance status of the subject 16 is observed, and the behavior of the medication, reporting, etc. in accordance with the instructions is observed in compliance with the instructions of the trial investigator 14.
治験が終了すると、治験実施者14または仲介者10は治験結果を作成し、治験依頼者12に提出する(ステップS124)。また仲介者10は被験者16の治験参加状況を治験依頼者12または治験実施者14に報告し、仲介手数料などの料金を計算し請求する(ステップS126)。 When the clinical trial is completed, the trial investigator 14 or the mediator 10 creates a clinical trial result and submits it to the clinical trial requester 12 (step S124). Further, the mediator 10 reports the clinical trial participation status of the subject 16 to the clinical trial client 12 or the clinical trial practitioner 14, and calculates and charges a fee such as a mediation fee (step S126).
(被験者募集手順)
次に前記治験参加希望者募集の手順(ステップS110)を図3、4に基づいて説明する。仲介者10は前記した治験依頼者12、治験実施者14との打合せ(ステップS108)に基づいて、被験者選定条件を設定し(ステップS200)、これを仲介者10のホームページ(HP)に提示する(ステップS202)。治験参加希望者(応募者)16はこれを確認して、治験参加の申し込み(登録)をする(ステップS204)。この申し込みに先行して事前に治験参加希望者16の応募を受付け(事前受付)することができるようにしても良い(事前登録)。この場合には、仲介者10は治験依頼者12や治験実施者14から治験者募集の依頼を受けて行った業務委受託契約に基づきホームページ(HP)を改訂し、これを事前登録した治験参加希望者に提示して参加を促す。
(Subject recruitment procedure)
Next, the procedure for recruiting clinical trial applicants (step S110) will be described with reference to FIGS. The mediator 10 sets subject selection conditions (step S200) based on the meeting (step S108) with the above-described clinical trial requester 12 and the clinical trial practitioner 14, and presents this on the mediator's 10 homepage (HP). (Step S202). The applicant (applicant) 16 who wishes to participate in the clinical trial confirms this and applies (registers) to participate in the clinical trial (step S204). Prior to this application, it may be possible to accept (pre-registration) the application of the trial applicant 16 in advance (pre-registration). In this case, the intermediary 10 revises the homepage (HP) based on the business consignment contract received in response to the recruitment of the trial applicants from the trial sponsor 12 or the trial practitioner 14, and participates in the trial that has been pre-registered. Present to the applicant and encourage participation.
なお治験実施者14と仲介者10との間のインターネット18を通したデータの送受信には、専用アプリケーションソフトを用いてセキュリティ機能を高めている。すなわち治験実施者14の端末機と仲介者10のサーバにはそれぞれ専用通信アプリケーションソフトを予め入力しておき、他の端末機では読出しできないようにする。また被験者16、仲介者10、治験実施者14の間のインターネット18を介したデータの送受には、一般的に用いられる暗号通信機能やID(個人認証)やPW(パスワード)などを用いる。 In addition, in the transmission and reception of data through the Internet 18 between the trial investigator 14 and the mediator 10, the security function is enhanced by using dedicated application software. That is, dedicated communication application software is previously input to the terminal of the trial investigator 14 and the server of the intermediary 10, respectively, so that it cannot be read by other terminals. For data transmission / reception between the subject 16, the mediator 10, and the trial investigator 14 via the Internet 18, a commonly used encryption communication function, ID (personal authentication), PW (password), or the like is used.
治験参加希望者(臨床試験参加希望者)がこの仲介者10の募集サイトを確認し(図3のステップS202)、応募すると(ステップS204)、仲介者10はこの応募者(治験参加希望者)にIDやPWを送る(ステップ206)。治験参加希望者16はこの送られてきたID/PWを仲介者10のサーバに送ることにより(ステップS208)、仲介者のサーバ10は日誌のフォーマットをこの治験参加希望者16に送る(ステップS210)。この時、治験者の選定条件も合わせて送る。例えばこの選定条件は、治験の対象者すなわち治験ルール、日程、地域、通院の可否などの条件である。この選定条件には、選定に要する期間(すなわち日誌を送り続ける期間)も含む。 When the trial applicant (clinical trial participant) confirms the recruitment site of the mediator 10 (step S202 in FIG. 3) and applies (step S204), the mediator 10 is the applicant (student applicant). ID and PW are sent to (step 206). The trial participant 16 sends the sent ID / PW to the server of the mediator 10 (step S208), and the mediator server 10 sends the diary format to the trial participant 16 (step S210). ). At this time, the selection conditions for the investigator will also be sent. For example, the selection condition is a condition such as a subject of a clinical trial, that is, a clinical trial rule, a schedule, a region, whether or not to go to hospital. This selection condition includes a period required for selection (that is, a period during which the diary is continuously sent).
日誌フォーマットは、例えば図6に一部を抽出して示すようなものである。この日誌では、朝食、起床時間など応募者の生活状況などを記入すると共に、その日の体調(疲れの程度)を直線上の位置で記入するようにしている。すなわち、この直線の左端Aを「疲れがない」とし、右端Bを「かなり疲れている」として、現在のつかれ具合をA〜B間の位置Cで表すように記入するものである。 The diary format is, for example, a part extracted and shown in FIG. In this diary, the applicant's living conditions such as breakfast and wake-up time are entered, and the physical condition of the day (degree of fatigue) is entered in a linear position. That is, the left end A of this straight line is “no fatigue” and the right end B is “substantially tired”, so that the current state of attachment is represented by a position C between A and B.
治験参加希望者16は、この選定条件を承諾すると日誌フォーマットに必要事項を記入(入力)して、定期的に(例えば毎日)仲介者10のサーバに送る(ステップS212)。仲介者10のサーバでは、この日誌の入力状況をチェックし、確認する(ステップS214)。またこの日誌の入力情報から、治験参加希望者16の体調を監視する(ステップS216)。例えば選定条件を予め設定値(設定範囲を含む。)として入力しておき、日誌入力情報をこの設定値と比較することによって体調の異常、変化を判定することができる。 If the trial applicant 16 accepts this selection condition, he / she enters (inputs) necessary information in the diary format and periodically (for example, every day) sends it to the server of the mediator 10 (step S212). The server of the broker 10 checks and confirms the input status of this diary (step S214). Further, the physical condition of the trial applicant 16 is monitored from the input information of the diary (step S216). For example, it is possible to determine abnormalities and changes in physical condition by inputting selection conditions in advance as set values (including a set range) and comparing the diary input information with the set values.
そしてこの入力情報を所定期間分まとめ、さらに体調監視結果と共に治験実施者14の端末機に送り、または読み取り可能な状態にする(ステップS218)。この場合はこの体調の変化を検出した時までの日誌入力情報を体調監視結果と共にまとめて治験実施者に送り、治験実施者が適切な治験者を選定する資料として利用できるようにする。ここで送る入力情報は、ステップS210の選定条件で設定した選定に要する全期間分や、途中時点での一定期間分を送るようにしても良い。選定に要する期間は数週間、数10日、数ヶ月などと設定されるので、長い期間の場合にはその途中で入力情報をまとめて送るようにしてもよい。 Then, the input information is collected for a predetermined period, and further sent to the terminal of the investigator 14 together with the physical condition monitoring result, or in a readable state (step S218). In this case, diary input information up to the time when this change in physical condition is detected is sent together with the physical condition monitoring result to the investigator so that the investigator can use it as data for selecting an appropriate investigator. The input information to be sent here may be sent for the entire period required for the selection set in the selection condition in step S210, or for a certain period at a midpoint. Since the period required for selection is set to several weeks, several tens of days, several months, etc., in the case of a long period, input information may be sent together during the period.
治験実施者14はこの入力情報から目的の治験に適合する応募者(治験参加希望者)16を選定して仲介者10に通知する(ステップS220)。仲介者10ではこの通知を受けて選定された治験参加希望者16に治験の確認と同意を得るための処理を行い(ステップS222)、治験参加希望者16の確認と同意を得て(ステップS224)、この確認/同意を得た治験参加希望者を治験候補者として確定し(ステップS226)、この治験候補者のリストを治験実施者14に送る(ステップS228)。すなわち治験実施者14がこのリストを閲覧可能な状態にする。なお仲介者10のサーバでは治験候補者の選定に際して、所定期間の日誌の入力情報に矛盾点が無いか、正直な内容であるかなどを判定し、信頼性を考慮するのが良い。 The trial investigator 14 selects an applicant (applicant for clinical trial participation) 16 that matches the target clinical trial from this input information and notifies the mediator 10 (step S220). The intermediary 10 performs a process for confirming and obtaining consent for the clinical trial participation candidate 16 selected in response to this notification (step S222), and obtaining confirmation and consent for the trial participation candidate 16 (step S224). The trial applicant who obtained this confirmation / agreement is confirmed as a trial candidate (step S226), and the list of trial candidates is sent to the trial practitioner 14 (step S228). In other words, the trial investigator 14 makes this list available for browsing. It should be noted that when selecting the trial candidate, the mediator 10 server determines whether there is no contradiction in the input information of the diary for a predetermined period or whether the information is honest, and so on, and it is preferable to consider the reliability.
治験実施者14はインターネット18を通して仲介者のサーバ10にアクセスしこの被験候補者のリストを閲覧し確認する。このリストは、仲介者10から治験実施者14に他の方法、例えばeメールやファクシミリ、郵便などで送って閲覧可能にしてもよい。そして治験実施者14は予定の日時に来院する被験候補者16をこのリストに基づいて診察し、検診して治験に対する適否を最終的に判定する(図2のステップS112)。 The investigator 14 accesses the intermediary server 10 through the Internet 18 and browses and confirms the list of candidate candidates. This list may be sent from the intermediary 10 to the trial investigator 14 by other methods such as e-mail, facsimile, mail, etc. so that the list can be viewed. Then, the trial investigator 14 examines the test candidates 16 who visit the hospital on the scheduled date and time based on this list, and finally judges the suitability for the trial (step S112 in FIG. 2).
この検診の結果は集計して治験実施者14からeメールやファクシミリやインターネットなどの適宜手段によって仲介者のサーバ10に送られる(図2のステップS116)。この報告は被験者16から受けることもある。仲介者10はこの報告に基づいて被験者のリストを作成すると共に、治験候補者に通知する(図2のステップS118)。 The results of this examination are totaled and sent from the trial investigator 14 to the mediator server 10 by appropriate means such as e-mail, facsimile, or the Internet (step S116 in FIG. 2). This report may be received from the subject 16. The mediator 10 creates a list of subjects based on this report and notifies the trial candidates (step S118 in FIG. 2).
合格した候補者に対して実施者14は治験を行い(図2のステップS120)、その結果が仲介者10に報告され(ステップS122)、仲介者10は料金を請求し(ステップS126)、治験結果を実施者14から受け取る。 The practitioner 14 conducts a clinical trial for the successful candidate (step S120 in FIG. 2), the result is reported to the mediator 10 (step S122), and the mediator 10 charges a fee (step S126). Results are received from the implementer 14.
なお図3のステップS228で行う被験候補者リストの作成においては、仲介者10は被験経験者についての実績データをサーバから読出し、該当する被験者16についての実績データを併記するのがよい。この実績データにより個々の被験者16の信頼性を確認することができ、信頼性の高い正直な参加者から得たデータを用いることにより治験結果の信頼性向上が図れるからである。 In the creation of the test candidate list performed in step S228 of FIG. 3, the mediator 10 may read the record data about the test experienced person from the server and write the record data about the subject 16 together. This is because the reliability of the individual subject 16 can be confirmed from the result data, and the reliability of the clinical trial results can be improved by using data obtained from highly reliable and honest participants.
(サーバの構成)
次に図1に示した仲介者のサーバ10の構成を図5に基づいて説明する。このサーバ10は前記した処理を行うために、ソフトウェアで構成された種々の機能部を持つ。すなわち図3に示すステップS202に対応する治験募集情報を提示し登録を促す募集画面提示部50、ステップS204に対応する参加申し込み受付部52、ステップS208に対応するID/PW送付部54を持つ。
(Server configuration)
Next, the configuration of the mediator server 10 shown in FIG. 1 will be described with reference to FIG. The server 10 has various functional units configured by software in order to perform the above-described processing. That is, it has a recruitment screen presentation unit 50 that presents clinical trial recruitment information corresponding to step S202 shown in FIG. 3 and prompts registration, a participation application reception unit 52 corresponding to step S204, and an ID / PW sending unit 54 corresponding to step S208.
またステップS210に対応する日誌フォーマット提示部56、応募者から定期的に送られて来る日誌の記憶部58、日誌の入力情報から応募者の体調変化を検出する体調監視部60、所定期間分の日誌の入力情報を治験実施者14に送る入力情報送信部62、治験実施者14が選出した治験条件適合者の参加意思を確認し同意を得るための確認/同意処理部64、参加意思の確認/同意を得た治験候補者のリストを作成するリスト作成部66などを持つ。なお募集画面、日誌フォーマット、記入済みの日誌、等のメモリや、種々の処理で必要となるメモリは共通としてもよい。 Further, a diary format presentation unit 56 corresponding to step S210, a diary storage unit 58 periodically sent from the applicant, a physical condition monitoring unit 60 that detects changes in the physical condition of the applicant from input information of the diary, and a predetermined period of time. Input information transmission unit 62 for sending log entry information to the trial practitioner 14, confirmation / consent processing unit 64 for confirming the intention of participation of the trial condition conformant selected by the trial practitioner 14, and confirmation of participation intention A list creation unit 66 for creating a list of clinical trial candidates who have obtained consent. Note that the memory for the recruitment screen, diary format, completed diary, etc., and the memory required for various processes may be common.
10 仲介者(のサーバ)
12 治験依頼者(の端末機)
14 治験実施者(の端末機)
16 治験希望者または応募者(の端末機)
18 インターネット
10 Broker (server)
12 Clinical trial client (terminal)
14 Clinical trial operator (terminal)
16 Trial applicant or applicant (terminal)
18 Internet
Claims (8)
a.前記仲介者のサーバは、前記治験の選定条件および治験募集情報を予め記憶し、このサーバが有する募集画面提示部は治験参加希望者の端末機に対してこの記憶した治験募集情報を示す画面を提示し登録の申込みを促す工程、
b.前記仲介者のサーバは、前記予め記憶した治験の被験者選定条件とともに日誌のフォーマットを予め記憶し、この予め記憶した日誌のフォーマットは血圧、体温を含む数値データの記入欄と疲れの程度を含む主観的感覚データを直線上の位置で示す記入欄を有し、このサーバが有するID/PW提示部は前記治験参加希望者の端末機から登録の申込みを受けて治験参加希望者の端末機に対して前記予め記憶した日誌のフォーマットの読み込みを可能にするID/PWを送る工程、
c.前記仲介者のサーバが有する日誌フォーマット提示部は、治験参加希望者から送られるID/PWを受けて前記予め記憶した日誌のフォーマットおよび前記選定条件を治験参加希望者の端末機に送る工程、
d.前記仲介者のサーバは、前記治験参加希望者の端末機から定期的に送られる日誌フォーマットに記入済みの日誌を読み込んで日誌記憶部に記憶すると共に、日誌の入力情報を前記予め記憶した選定条件となる設定値と比較することによって前記治験参加希望者の体調を体調監視部で監視し治験実行に好適なタイミングを検知する工程、
e.前記仲介者のサーバは、このタイミングを検知すると、前記治験参加希望者の端末機から送られ前記日誌記憶部に記憶された日誌の所定期間分の入力情報を、前記体調監視部で監視した治験参加希望者の体調監視結果と共に前記治験実施者の端末機で読み取り可能にする工程、
f.前記仲介者のサーバが有する参加確認/同意処理部は、前記予め記憶した選定条件に適合する治験参加希望者の端末機に対して参加意思の確認/同意を促す工程、
g.前記仲介者のサーバが有するリスト作成部は、前記治験実施者の端末機に対して前記確認/同意を得た治験参加希望者を治験候補者とするリストを送付する工程、
以上のa〜gの工程を有するコンピュータを用いた被験者募集/選定方法。 In the method of recruiting and selecting subjects using a computer, an intermediary that introduces subjects who meet the clinical trial selection conditions to the trial investigator recruits and selects subjects via the Internet.
a. The intermediary server stores the clinical trial selection conditions and clinical trial recruitment information in advance, and the recruitment screen presenting unit of the server displays a screen showing the stored clinical trial recruitment information for the terminal of the trial participation applicant. Process of presenting and encouraging registration,
b. The intermediary server pre-stores a diary format together with the pre-stored trial selection conditions for the trial, and the pre-stored diary format includes a column for numerical data including blood pressure and body temperature, and a subjectivity including the degree of fatigue. The ID / PW presentation section of this server has an application for registration from the terminal of the applicant who wishes to participate in the trial. Sending an ID / PW that enables reading of the previously stored diary format;
c. The diary format presentation unit of the mediator server receives the ID / PW sent from the trial applicant and sends the pre-stored diary format and the selection conditions to the trial participant's terminal.
d. The intermediary server reads the diary that is filled in the diary format periodically sent from the terminal of the trial applicant, stores the diary in the diary storage unit, and the pre-stored selection condition for the diary input information. A step of monitoring the physical condition of the applicant who wishes to participate in the trial by a physical condition monitoring unit by comparing with a set value to be detected and detecting a suitable timing for performing the trial ,
e. When the intermediary server detects this timing , the physical condition monitoring unit monitors the input information for a predetermined period of the diary sent from the terminal of the trial applicant and stored in the diary storage unit. Making it possible to read the physical condition monitoring result of the applicant who wishes to participate in the terminal of the investigator,
f. The participation confirmation / consent processing unit possessed by the server of the intermediary is a step of prompting confirmation / agreement of participation intention to a terminal of a trial applicant who meets the selection conditions stored in advance.
g. List generating unit that server of the intermediary has, the step of sending the list to the study candidate clinical trial participants who wish to obtain the confirmation / consent to the terminal of the trial practitioner,
A subject recruitment / selection method using a computer having the steps a to g.
治験の選定条件および治験募集情報を予め記憶し、治験参加希望者の端末機に対してこの記憶した治験募集情報を提示し登録を促す募集画面提示部と、
前記治験参加希望者の端末機から入力される登録申込信号を受付ける参加申込み受付部と、
前記予め記憶した治験の選定条件とともに、血圧を含む数値データの記入欄と疲れの程度を含む主観的感覚データを直線上の位置で示す記入欄を有する日誌のフォーマットとを予め記憶し、前記登録申込信号を受け付けてこの日誌のフォーマットの読出し用のID/PWを参加申込者である応募者の端末機に送るID/PW送付部と、
ID/PWを受け付けて前記日誌のフォーマットおよび前記選定条件を治験参加希望者である応募者の端末機に提示する日誌フォーマット提示部と、
応募者の端末機から定期的に送られる日誌を読み込んで記憶する日誌記憶部と、
日誌の入力情報を選定条件となる設定値と比較し体調の変化を監視し治験実行に好適なタイミングを検知する体調監視部と、
このタイミングを検知すると、応募者の端末機から送られた日誌の所定期間分の入力情報を前記日誌記憶部から読み出して前記体調監視部の体調監視結果と共に治験実施者の端末機に送る入力情報送信部と、
治験実施者の端末機から送られてくる治験条件適合者に治験参加意思の確認/同意を取るための確認/同意処理部と、
治験参加意思の確認/同意を得た応募者を治験候補者として、この治験候補者のリストを作成し治験実施者の端末機による閲覧を可能にするリスト作成部と、
を備えることを特徴とする被験者募集仲介者のサーバ。 An intermediary server used in the method of claim 1,
Recruitment screen presentation unit for preliminarily storing clinical trial selection conditions and clinical trial recruitment information, and presenting the stored clinical trial recruitment information to the terminals of those who wish to participate in the clinical trial,
A participation application receiving unit that receives a registration application signal input from a terminal of the trial applicant.
In addition to the pre-stored clinical trial selection conditions, a diary format having an entry field for numerical data including blood pressure and an entry field for indicating subjective sensory data including the degree of fatigue on a straight line is stored in advance, and the registration is performed. An ID / PW sending unit that accepts an application signal and sends ID / PW for reading out the format of this diary to the terminal of the applicant who is a participating applicant;
A diary format presentation unit that accepts an ID / PW and presents the format of the diary and the selection conditions on the terminal of the applicant who is the applicant for the trial ;
A diary storage unit that reads and stores diaries periodically sent from the applicant's terminal;
A physical condition monitoring unit that compares the input information of the diary with a set value that is a selection condition , monitors changes in physical condition, and detects a suitable timing for performing the trial ;
When this timing is detected , input information for a predetermined period of the diary sent from the applicant's terminal is read from the diary storage unit and sent to the trial investigator's terminal together with the physical condition monitoring result of the physical condition monitoring unit A transmission unit;
A confirmation / consent processing unit for confirming / consenting the intention to participate in the trial to the trial condition conformant sent from the terminal of the trial investigator;
An applicant who has confirmed / consented the intention to participate in the trial as a trial candidate, creates a list of trial candidates, and allows the trial investigator's terminal to view the list,
A server for recruiting intermediaries for subjects.
治験の選定条件および治験募集情報を予め記憶し、治験参加希望者の端末機に対してこの記憶した治験募集情報を提示し登録を促す募集画面提示部と、
前記治験参加希望者の端末機から入力される登録申込信号を受付ける参加申込み受付部と、
前記予め記憶した治験の選定条件とともに、血圧を含む数値データの記入欄と疲れの程度を含む主観的感覚データを直線上の位置で示す記入欄を有する日誌のフォーマットとを予め記憶し、前記登録申込信号を受け付けてこの日誌のフォーマットの読出し用のID/PWを参加申込者である応募者の端末機に送るID/PW送付部と、
ID/PWを受け付けて前記日誌のフォーマットおよび前記選定条件を治験参加希望者である応募者の端末機に提示する日誌フォーマット提示部と、
応募者の端末機から定期的に送られる日誌を読み込んで記憶する日誌記憶部と、
日誌の入力情報を選定条件となる設定値と比較し体調の変化を監視し治験実行に好適なタイミングを検知する体調監視部と、
このタイミングを検知すると、応募者の端末機から送られた日誌の所定期間分の入力情報を前記日誌記憶部から読み出して前記体調監視部の体調監視結果と共に治験実施者の端末機に送る入力情報送信部と、
治験実施者の端末機から送られてくる治験条件適合者に治験参加意思の確認/同意を取るための確認/同意処理部と、
治験参加意思の確認/同意を得た応募者を治験候補者として、この治験候補者のリストを作成し治験実施者の端末機による閲覧を可能にするリスト作成部として機能させるためのプログラム。 Computer software used in the method of claim 1, wherein the server is
Recruitment screen presentation unit for preliminarily storing clinical trial selection conditions and clinical trial recruitment information, and presenting the stored clinical trial recruitment information to the terminals of those who wish to participate in the clinical trial,
A participation application receiving unit that receives a registration application signal input from a terminal of the trial applicant.
In addition to the pre-stored clinical trial selection conditions, a diary format having an entry field for numerical data including blood pressure and an entry field for indicating subjective sensory data including the degree of fatigue on a straight line is stored in advance, and the registration is performed. An ID / PW sending unit that accepts an application signal and sends ID / PW for reading out the format of this diary to the terminal of the applicant who is a participating applicant;
A diary format presentation unit that accepts an ID / PW and presents the format of the diary and the selection conditions on the terminal of the applicant who is the applicant for the trial;
A diary storage unit that reads and stores diaries periodically sent from the applicant's terminal;
A physical condition monitoring unit that compares the input information of the diary with a set value that is a selection condition, monitors changes in physical condition, and detects a suitable timing for performing the trial ;
When this timing is detected , input information for a predetermined period of the diary sent from the applicant's terminal is read from the diary storage unit and sent to the trial investigator's terminal together with the physical condition monitoring result of the physical condition monitoring unit A transmission unit;
A confirmation / consent processing unit for confirming / consenting the intention to participate in the trial to the trial condition conformant sent from the terminal of the trial investigator;
A program for functioning as a list creation unit that creates a list of clinical trial candidates and allows the trial applicant to view the trial candidates with the applicants who have confirmed / consent the intention to participate in the trial as clinical trial candidates.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010105014A JP5073008B2 (en) | 2010-04-30 | 2010-04-30 | Subject recruitment method, mediator server, software, recording medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010105014A JP5073008B2 (en) | 2010-04-30 | 2010-04-30 | Subject recruitment method, mediator server, software, recording medium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011233066A JP2011233066A (en) | 2011-11-17 |
| JP5073008B2 true JP5073008B2 (en) | 2012-11-14 |
Family
ID=45322298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010105014A Active JP5073008B2 (en) | 2010-04-30 | 2010-04-30 | Subject recruitment method, mediator server, software, recording medium |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5073008B2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014102797A (en) * | 2012-11-22 | 2014-06-05 | Fujitsu Ltd | Medical examination plan preparing program, medical examination plan preparation device, and medical examination plan preparation method |
| JP6338957B2 (en) * | 2014-07-22 | 2018-06-06 | 株式会社メディカルフロント | Clinical trial compatible patient selection device, system and method |
| WO2018190481A1 (en) * | 2017-04-11 | 2018-10-18 | 주식회사 에이치비에이 | Method for rendering clinical trial information in medical examination format between clinical trial volunteers and medical institution conducting clinical trial |
| WO2018190480A1 (en) * | 2017-04-11 | 2018-10-18 | 주식회사 에이치비에이 | System for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial |
| WO2018190479A1 (en) * | 2017-04-11 | 2018-10-18 | 주식회사 에이치비에이 | Method for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial |
| KR102321469B1 (en) * | 2019-04-05 | 2021-11-04 | (주)올리브헬스케어 | Smart e-consent system for clinical trial participant, and method thereof |
| KR102536747B1 (en) * | 2020-02-05 | 2023-05-30 | 강성일 | Method and System for intermediating project |
| WO2021157832A1 (en) * | 2020-02-05 | 2021-08-12 | 강성일 | System and method for mediating project |
| JP7423815B2 (en) * | 2020-10-20 | 2024-01-29 | セトラスホールディングス株式会社 | Clinical trial management device, clinical trial management method, clinical trial management program, and clinical trial management system |
| KR102812294B1 (en) * | 2021-12-31 | 2025-05-26 | 주식회사 휴마트컴퍼니 | Mental health-related clinical trial institution and clinical trial participant matching system and method |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002056099A (en) * | 2000-08-11 | 2002-02-20 | Ntt Me Corp | Health management system |
| JP2003263486A (en) * | 2002-03-07 | 2003-09-19 | Progress Interactive Inc | Server system for generating data totalizing calendar |
| JP2004029894A (en) * | 2002-06-21 | 2004-01-29 | Moss Institute Co Ltd | Case registration system, case registration information processing device, case registration method, and case registration program |
| JP2004185067A (en) * | 2002-11-29 | 2004-07-02 | Wellness:Kk | Subject suitability judgment system |
| JP2007011442A (en) * | 2005-06-28 | 2007-01-18 | Wataru Sekiguchi | Clinical trial contract system and clinical trial contract program |
| JP5076128B2 (en) * | 2006-12-15 | 2012-11-21 | ノイエス株式会社 | Clinical trial monitoring system and clinical trial monitoring server |
| JP4697972B2 (en) * | 2006-12-28 | 2011-06-08 | 株式会社ヒューマ | Subject recruitment method, mediator server, software, recording medium |
| JP4463300B2 (en) * | 2007-11-09 | 2010-05-19 | 株式会社ヒューマ | Subject management method and apparatus |
-
2010
- 2010-04-30 JP JP2010105014A patent/JP5073008B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011233066A (en) | 2011-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5073008B2 (en) | Subject recruitment method, mediator server, software, recording medium | |
| Modi et al. | Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis | |
| Stratton et al. | Developing an indicator of family function and a practicable outcome measure for systemic family and couple therapy: the SCORE | |
| Strecher et al. | Moderators and mediators of a web-based computer-tailored smoking cessation program among nicotine patch users | |
| Kearney et al. | Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study | |
| Shields et al. | Rochester participatory decision-making scale (RPAD): reliability and validity | |
| Haberer et al. | Furthering the reliable and valid measurement of mental health screening, diagnoses, treatment and outcomes through health information technology | |
| Matza et al. | A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes | |
| Wahyuni | Explaining acceptance of e-health services: An extension of TAM and health belief model approach | |
| Goodyear-Smith et al. | Recruitment of practices in primary care research: the long and the short of it | |
| Dolovich et al. | The Diabetes Continuity of Care Scale: the development and initial evaluation of a questionnaire that measures continuity of care from the patient perspective | |
| Laur et al. | Comparing hospital staff nutrition knowledge, attitudes, and practices before and 1 year after improving nutrition care: results from the More‐2‐Eat implementation project | |
| Joensen et al. | Validation of the type 1 diabetes distress scale (T1-DDS) in a large Danish cohort: content validation and psychometric properties | |
| Mou et al. | Trust, risk barriers and health beliefs in consumer acceptance of online health services | |
| de Jong et al. | Opportunities and challenges for decentralized clinical trial approaches: European health technology assessment perspective | |
| Du Pon et al. | Effects of the Proactive Interdisciplinary Self‐Management (PRISMA) Program on Online Care Platform Usage in Patients with Type 2 Diabetes in Primary Care: A Randomized Controlled Trial | |
| Hyman | Brief interventions for high‐risk drinkers | |
| Bailey et al. | The Men's Safer Sex (MenSS) trial: protocol for a pilot randomised controlled trial of an interactive digital intervention to increase condom use in men | |
| Johnson-Kwochka et al. | Treatment completion among justice-involved youth engaged in behavioral health treatment studies in the United States: A systematic review and meta-analysis | |
| Benham et al. | Treat‐to‐target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real‐Time Anonymous Liaison system: The RA T2T PORTAL study | |
| Mukherjee et al. | Symptom burden in patients with idiopathic multicentric Castleman disease and its impact on daily life: an international patient and caregiver survey | |
| Sederer et al. | Assessing outcomes in clinical practice | |
| Lau | Encouraging the use of ehealth services: A survey of patients’ experiences | |
| Groot et al. | Optimising personal continuity for older patients in general practice: a study protocol for a cluster randomised stepped wedge pragmatic trial | |
| Grove et al. | Remote symptom monitoring using patient-reported outcomes in patients with chronic kidney disease: process evaluation of a randomized controlled trial |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120727 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120821 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5073008 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150831 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |